Ksenia Titorenko

3PUBLICATIONS
12CO-AUTHORS
Infant and child healthLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Sep 22, 2023
The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study.

Nobuko Hijiya, Alexey Maschan, Carmelo Rizzari

|Jul 26, 2021
A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety.

Nobuko Hijiya, Alexey Maschan, Carmelo Rizzari

|Mar 12, 2021
Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial.

Jerald P Radich, Andreas Hochhaus, Tamás Masszi

Pageof 1

Frequent Collaborators

2 joint publications

Nobuko Hijiya

2 joint publications

Alexey Maschan

2 joint publications

Carmelo Rizzari

2 joint publications

Hiroyuki Shimada

2 joint publications

Jill Samis

2 joint publications

Darintr Sosothikul

1 joint publications

Tamás Masszi

1 joint publications

J Valentín García-Gutiérrez

1 joint publications

Susanne Saussele

1 joint publications

David M Ross

Frequent Collaborators

2 joint publications

Nobuko Hijiya

2 joint publications

Alexey Maschan

2 joint publications

Carmelo Rizzari

2 joint publications

Hiroyuki Shimada

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.2K
Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

486
See more related videos

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.2K
Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

486
See more related videos